Shane Schaffer on Spreaker
Ep. 860 Dr. Shane Schaffer | Life-Changing Work that is Worth the Wait
Published on Outsourcing-Pharma
Important Announcement
Dear readers, We would like to share some important news with…
Published on Psychiatric Times
Positive Top-Line Results Reported for Fed/Fast Study of Novel ADHD Treatment
The fed/fast study, CTx-1301-003, is an endeavor by Cingulate…
Watch on YouTube
This week our CEO, Shane Schaffer, rejoined the Big Biz Show to further discuss Cingulate’s pipeline
Watch on YouTube
Cingulate Initiates Final Study for Lead ADHD Asset
Cingulate is a clinical stage biopharmaceutical company focused…
Watch on YouTube
Cingulate’s Shane Schaffer Interviewed by Nationally Syndicated Big Biz Show
Cingulate’s Shane Schaffer recently joined the cast of…
Watch on YouTube
Cingulate The Future Of ADHD Medicine As We Review With The CEO
Watch on YouTube